Specifically, FDA cited the failure to sufficiently evaluate and select a new vendor as the supplier of a critical device component, and the failure to adequately validate the continued safety and effectiveness of the hearing aid by testing lots under actual or simulated use when the unapproved vendor's component was used. The failure was first noted at a 2001 inspection.